6:00 PM
Oct 04, 2012
 |  BC Extra  |  Politics & Policy

France launching regulatory process for off-label use

France is implementing a regulatory process to temporarily authorize the use of selected drugs in off-label indications, according to a paper published in The New England Journal of Medicine by members of the country's revamped drug regulatory agency.


Read the full 182 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >